Skip to content
Review

Targeting the Immune System with Nanoparticles: A Comprehensive Review on Immunomodulation.

Sep 2026 · Current pharmaceutical design · Vol 32 · 0 citations
Medicine

TL;DR

Significant advancements in NP-based immunomodulation offer effective alternatives to conventional therapies, with AI-assisted design and personalized nanomedicine identified as significant future directions.

Abstract

INTRODUCTION The immune system plays a significant role in combating pathogens, maintaining homeostasis, and protecting the overall well-being of the body. Modulating the immune system to enhance or suppress the immune response is a remarkable approach against several diseases. The objective of this article is to comprehensively review the role of nanoparticles (NPs) in modulating the immune response.

Methods

This review discusses and analyzes current literature on how NPs can alter the immune response, detailing the different types of nanomaterials used, their specific mechanisms of action, and their interactions with immune cells.

Discussion

NPs are significantly impacting the field of immunomodulation through targeted drug delivery, effectively solving major pharmacological challenges like systemic side effects and low bioavailability. These novel therapeutic agents provide improved efficacy compared to traditional methods. Additionally, the review highlights the significant potential and ongoing applications of NPs in specialized areas, specifically in cancer immunotherapy and advanced vaccine development.

Conclusion

Significant advancements in NP-based immunomodulation offer effective alternatives to conventional therapies. Challenges, including nanotoxicity, manufacturing scalability, and clinical translation, must be addressed, with AI-assisted design and personalized nanomedicine identified as significant future directions.

View source

Similar papers

Review Open access 2026

Immunological Interactions of Carbon Nanomaterials: Translational Perspectives in Oncology Drug Development

Carbon nanomaterials have gained attention because of their unique physico-chemical properties, such as high surface area, structural versatility, and ease of functionalization, and are highlighted as potential strategies to improve targeting, reduce adverse effects, and facilitate integration with current immunotherap...

Davide Frumento, Ș. Țălu · 0 citations
Review Open access Oct 2026

Advances and projects of immunomodulatory biomaterials used for immunotherapy

Immunotherapy is employed to manage systemic hyperactivation or hypoactivation for the treatment of various diseases. Biomaterial-based immunotherapy systems have the potential to enhance therapeutic outcomes through mechanisms such as targeted drug delivery and immuno-engineering, among others. Nevertheless, the immun...

Davide Frumento, Niranjan Patra · 0 citations
Review Open access Sep 2026

Green-Synthesized Nanomaterials for Kidney Cancer: Current Progress and Future Perspectives

The current role of green-synthesized NPs in renal cell carcinoma management and their applications in targeted drug delivery and cancer-specific targeting mechanisms are focused on and the environmentally friendly green synthesis approaches utilizing biological resources such as plant extracts and microorganisms are h...

Mariam R. Khalifa, Doaa S. R. Khafaga, Marwa T. Abo Gabal et al. · 0 citations
Review Sep 2026

Advances in Nanocarrier Drug Delivery Systems for the Treatment of Systemic Lupus Erythematosus

Although further investigation is needed to address safety and translational barriers, continued development of nanomedicine platforms holds significant potential to improve disease control and enhance the quality of life for patients with SLE.

Raghad Nawasrah, Mohammad A. Obeid · 0 citations
Review Open access Sep 2026

Targeting the Immunosuppressive Microenvironment in Colorectal Cancer: Pharmacological and Nanomedicine Strategies

The fundamental immunosuppressive interactions within the TME are discussed and subsequently it is examined how these agents enhance immune responses by reprogramming stromal and immune cells, as well as their secreted mediators within the TIME.

Qamar Abuhassan, Usamah Sayed, Pareshkumar N. Patel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.